{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:05:36Z","timestamp":1707523536004},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,22]]},"DOI":"10.7759\/cureus.35290","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T10:07:58Z","timestamp":1677060478000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe COVID-19 as a Possible Mediator of Autoimmunity and Sj\u00f6gren\u2019s Syndrome"],"prefix":"10.7759","author":[{"given":"Kazuhisa","family":"Konishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroomi","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu Z","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020, 323:1239-42. 10.1001\/jama.2020.2648","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117179","article-title":"Post-COVID 19 neurological syndrome (PCNS); a novel syndrome with challenges for the global neurology community","volume":"419","author":"Wijeratne T","year":"2020","unstructured":"Wijeratne T, Crewther S. Post-COVID 19 neurological syndrome (PCNS); a novel syndrome with challenges for the global neurology community. J Neurol Sci. 2020, 419:117179. 10.1016\/j.jns.2020.117179","journal-title":"J Neurol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.01.004","article-title":"Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study","volume":"82","author":"Moreno-P\u00e9rez O","year":"2021","unstructured":"Moreno-P\u00e9rez O, Merino E, Leon-Ramirez JM, et al.. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021, 82:378-83. 10.1016\/j.jinf.2021.01.004","journal-title":"J Infect"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12953","article-title":"SARS-CoV-2 infection as a trigger of autoimmune response","volume":"14","author":"Sacchi MC","year":"2021","unstructured":"Sacchi MC, Tamiazzo S, Stobbione P, et al.. SARS-CoV-2 infection as a trigger of autoimmune response. Clin Transl Sci. 2021, 14:898-907. 10.1111\/cts.12953","journal-title":"Clin Transl Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret P","year":"2020","unstructured":"Gautret P, Lagier JC, Parola P, et al.. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020, 56:105949. 10.1016\/j.ijantimicag.2020.105949","journal-title":"Int J Antimicrob Agents"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01897-20","article-title":"A prospective, randomized, open-label trial of early versus late favipiravir therapy in hospitalized patients with COVID-19","volume":"64","author":"Doi Y","year":"2020","unstructured":"Doi Y, Hibino M, Hase R, et al.. A prospective, randomized, open-label trial of early versus late favipiravir therapy in hospitalized patients with COVID-19. Antimicrob Agents Chemother. 2020, 64:e01897. 10.1128\/AAC.01897-20","journal-title":"Antimicrob Agents Chemother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa478","article-title":"Infectious Diseases Society of America Guidelines on the treatment and management of patients with COVID-19","author":"Bhimraj A","year":"2020","unstructured":"Bhimraj A, Morgan RL, Shumaker AH, et al.. Infectious Diseases Society of America Guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis. 2020, ciaa478. 10.1093\/cid\/ciaa478","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.03.002","article-title":"Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses","volume":"54","author":"Zheng H","year":"2021","unstructured":"Zheng H, Rao AM, Dermadi D, et al.. Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses. Immunity. 2021, 54:753-68. 10.1016\/j.immuni.2021.03.002","journal-title":"Immunity"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147413","article-title":"COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes","volume":"6","author":"MacDonald L","year":"2021","unstructured":"MacDonald L, Alivernini S, Tolusso B, et al.. COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes. JCI Insight. 2021, 6:e147413. 10.1172\/jci.insight.147413","journal-title":"JCI Insight"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.832394","article-title":"The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections","volume":"13","author":"Hsu RJ","year":"2022","unstructured":"Hsu RJ, Yu WC, Peng GR, et al.. The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections. Front Immunol. 2022, 13:832394. 10.3389\/fimmu.2022.832394","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo D","year":"2020","unstructured":"Blanco-Melo D, Nilsson-Payant BE, Liu WC, et al.. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020, 181:1036-45. 10.1016\/j.cell.2020.04.026","journal-title":"Cell"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05230-0","article-title":"Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review","volume":"39","author":"He F","year":"2020","unstructured":"He F, Luo Q, Lei M, et al.. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review. Clin Rheumatol. 2020, 39:2803-10. 10.1007\/s10067-020-05230-0","journal-title":"Clin Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.111075","article-title":"Detection of HTLV-1 in the labial salivary glands of patients with Sj\u00f6gren\u2019s syndrome: a distinct clinical subgroup?","volume":"39","author":"Lee SJ","year":"2012","unstructured":"Lee SJ, Lee JS, Shin MG, et al.. Detection of HTLV-1 in the labial salivary glands of patients with Sj\u00f6gren\u2019s syndrome: a distinct clinical subgroup?. J Rheumatol. 2012, 39:809-15. 10.3899\/jrheum.111075","journal-title":"J Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/v11080762","article-title":"Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms","volume":"11","author":"Smatti MK","year":"2019","unstructured":"Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2019, 11:762. 10.3390\/v11080762","journal-title":"Viruses"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67462-z","article-title":"Prevalence of Sj\u00f6gren's syndrome in the general adult population in Spain: estimating the proportion of undiagnosed cases","volume":"10","author":"Narv\u00e1ez J","year":"2020","unstructured":"Narv\u00e1ez J, S\u00e1nchez-Fern\u00e1ndez S\u00c1, Seoane-Mato D, D\u00edaz-Gonz\u00e1lez F, Bustabad S. Prevalence of Sj\u00f6gren's syndrome in the general adult population in Spain: estimating the proportion of undiagnosed cases. Sci Rep. 2020, 10:10627. 10.1038\/s41598-020-67462-z","journal-title":"Sci Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009629","article-title":"Modeling the onset of symptoms of COVID-19: effects of SARS-CoV-2 variant","volume":"17","author":"Larsen JR","year":"2021","unstructured":"Larsen JR, Martin MR, Martin JD, Hicks JB, Kuhn P. Modeling the onset of symptoms of COVID-19: effects of SARS-CoV-2 variant. PLoS Comput Biol. 2021, 17:e1009629. 10.1371\/journal.pcbi.1009629","journal-title":"PLoS Comput Biol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265233","article-title":"Visualizing omicron: COVID-19 deaths vs. cases over time","volume":"17","author":"Arnaout R","year":"2022","unstructured":"Arnaout R, Arnaout R. Visualizing omicron: COVID-19 deaths vs. cases over time. PLoS One. 2022, 17:e0265233. 10.1371\/journal.pone.0265233","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01104-y","article-title":"Pathological sequelae of long-haul COVID","volume":"23","author":"Mehandru S","year":"2022","unstructured":"Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022, 23:194-202. 10.1038\/s41590-021-01104-y","journal-title":"Nat Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/134294-severe-covid-19-as-a-possible-mediator-of-autoimmunity-and-sjgrens-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:48Z","timestamp":1707508188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/134294-severe-covid-19-as-a-possible-mediator-of-autoimmunity-and-sjgrens-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.35290","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,22]]}}}